Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanta Horie

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Annals of Neurology|January 6, 2025
Lecanemab-Associated Amyloid-β Protofibril in Cerebrospinal Fluid Correlates with Biomarkers of Neurodegeneration in Alzheimer's DiseaseMoeko Noguchi-Shinohara, Kazuyoshi Shuta, Hidetomo Murakami, et al.
Toxicologic Pathology|March 22, 2018
Histopathologic Characterization of Mifepristone-induced Ovarian Toxicity in Cynomolgus MonkeysYoshikazu Taketa, Kanta Horie, Tetsuya Goto, et al.
Acta Neuropathologica Communications|August 29, 2020
Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brainKanta Horie, Nicolas R Barthélemy, Nipun Mallipeddi, et al.
Molecular Psychiatry|May 6, 2020
TFEB regulates lysosomal exocytosis of tau and its loss of function exacerbates tau pathology and spreadingYin Xu, Shuqi Du, Jacob A Marsh, et al.
Translational Psychiatry|December 9, 2022
Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degenerationSidhartha Mahali, Rita Martinez, Melvin King, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 31, 2025
Combining CSF MTBR-tau243 and plasma pTau217 ratio enhances the prediction of continuous regional tau PET burden in early Alzheimer's diseaseViswanath Devanarayan, Kanta Horie, Kristin Wildsmith, et al.
NPJ Systems Biology and Applications|March 6, 2026
Neuro-Dynamic Quantitative Systems Pharmacology (QSP) model describing Alzheimer's disease pathophysiology and treatment effectsYoufang Cao, Brian A Willis, Kanta Horie, et al.
Alzheimer Disease and Associated Disorders|July 17, 2025
An Anti-tau Therapeutic Antibody Etalanetug (E2814): A Phase 1, First-in-human (FIH) Study of Single and Multiple Ascending Doses in Healthy SubjectsSumit Rawal, Kristin R Wildsmith, Jagadeesh Aluri, et al.
JCI Insight|December 7, 2021
Astrocytic 4R tau expression drives astrocyte reactivity and dysfunctionLubov A Ezerskiy, Kathleen M Schoch, Chihiro Sato, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersNiklas Mattsson-Carlgren, Sebastian Palmqvist, Kanta Horie, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Annals of Neurology|January 6, 2025
Lecanemab-Associated Amyloid-β Protofibril in Cerebrospinal Fluid Correlates with Biomarkers of Neurodegeneration in Alzheimer's DiseaseMoeko Noguchi-Shinohara, Kazuyoshi Shuta, Hidetomo Murakami, et al.
Toxicologic Pathology|March 22, 2018
Histopathologic Characterization of Mifepristone-induced Ovarian Toxicity in Cynomolgus MonkeysYoshikazu Taketa, Kanta Horie, Tetsuya Goto, et al.
Acta Neuropathologica Communications|August 29, 2020
Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brainKanta Horie, Nicolas R Barthélemy, Nipun Mallipeddi, et al.
Molecular Psychiatry|May 6, 2020
TFEB regulates lysosomal exocytosis of tau and its loss of function exacerbates tau pathology and spreadingYin Xu, Shuqi Du, Jacob A Marsh, et al.
Translational Psychiatry|December 9, 2022
Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degenerationSidhartha Mahali, Rita Martinez, Melvin King, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 31, 2025
Combining CSF MTBR-tau243 and plasma pTau217 ratio enhances the prediction of continuous regional tau PET burden in early Alzheimer's diseaseViswanath Devanarayan, Kanta Horie, Kristin Wildsmith, et al.
NPJ Systems Biology and Applications|March 6, 2026
Neuro-Dynamic Quantitative Systems Pharmacology (QSP) model describing Alzheimer's disease pathophysiology and treatment effectsYoufang Cao, Brian A Willis, Kanta Horie, et al.
Alzheimer Disease and Associated Disorders|July 17, 2025
An Anti-tau Therapeutic Antibody Etalanetug (E2814): A Phase 1, First-in-human (FIH) Study of Single and Multiple Ascending Doses in Healthy SubjectsSumit Rawal, Kristin R Wildsmith, Jagadeesh Aluri, et al.
JCI Insight|December 7, 2021
Astrocytic 4R tau expression drives astrocyte reactivity and dysfunctionLubov A Ezerskiy, Kathleen M Schoch, Chihiro Sato, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersNiklas Mattsson-Carlgren, Sebastian Palmqvist, Kanta Horie, et al.
Pageof 6